Last update 01 Dec 2025

Hexavalent Influenza mRNA Vaccine(Sanofi Pasteur)

Overview

Basic Info

Drug Type
Prophylactic vaccine, mRNA vaccine
Synonyms
Hexavalent Influenza mRNA HA + mRNA NA Vaccine(Sanofi Pasteur), SP-0289, SP0289
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Influenza, Human
Inactive Indication-
Originator Organization
Sanofi Pasteur SASanofi Pasteur SA
Active Organization
Sanofi Pasteur SASanofi Pasteur SA
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Hexavalent Influenza mRNA Vaccine(Sanofi Pasteur)
NCT06744205
/ Active, not recruitingPhase 1/2
A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older
100 Clinical Results associated with Hexavalent Influenza mRNA Vaccine(Sanofi Pasteur)
Login to view more data
100 Translational Medicine associated with Hexavalent Influenza mRNA Vaccine(Sanofi Pasteur)
Login to view more data
100 Patents (Medical) associated with Hexavalent Influenza mRNA Vaccine(Sanofi Pasteur)
Login to view more data
100 Deals associated with Hexavalent Influenza mRNA Vaccine(Sanofi Pasteur)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza, HumanPhase 2
United States
Sanofi Pasteur SASanofi Pasteur SA
06 Jan 2025
Influenza, HumanPhase 2
Australia
Sanofi Pasteur SASanofi Pasteur SA
06 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free